論文

国際誌
2022年1月22日

Evaluation of indices for predicting recovery of exercise tolerance in patients surviving allogenic hematopoietic stem cell transplantation.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
  • Ryota Hamada
  • Tadakazu Kondo
  • Kazuhiro Harada
  • Masanobu Murao
  • Junsuke Miyasaka
  • Michiko Yoshida
  • Honami Yonezawa
  • Manabu Nankaku
  • Yasuyuki Arai
  • Junya Kanda
  • Akifumi Takaori-Kondo
  • Ryosuke Ikeguchi
  • Shuichi Matsuda
  • 全て表示

記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1007/s00520-022-06822-z

PURPOSE: Decline in physical function in the early stage after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a major challenge. Exercise tolerance tests, such as the 6-min walk test, are useful markers for predicting exercise tolerance and various other traits, including cardiometabolic risk and non-relapse mortality. This retrospective cohort study aimed to investigate and identify predictors of recovery of exercise tolerance in the early stage after allo-HSCT. METHODS: Ninety-eight patients were classified into recovery and non-recovery groups according to the median 6-min walk distance (6MWD) at discharge. RESULTS: Logistic regression analysis revealed that pre-post change in knee extensor strength (ΔKES) and hematopoietic cell transplantation comorbidity index were useful predictors of recovery of exercise tolerance at discharge and moderate predictors of 6MWD recovery in the early post-transplant period. Receiver operating characteristic analysis showed that pre-transplant ΔKES was an accurate predictor of 6MWD recovery in the early post-transplant period. The cutoff point for ΔKES calculated using the Youden index was - 1.17 Nm/kg. CONCLUSIONS: The results of this study emphasize the importance of the need for programs designed to prevent muscle weakness in the early period after allo-HSCT. The results from markers of recovery of exercise tolerance are promising and can be used for patient education in rehabilitation programs after allo-HSCT.

リンク情報
DOI
https://doi.org/10.1007/s00520-022-06822-z
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/35066668
ID情報
  • DOI : 10.1007/s00520-022-06822-z
  • PubMed ID : 35066668

エクスポート
BibTeX RIS